Kynam Capital Management’s Burning Rock Biotech BNR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.14M | Hold |
994,883
| – | – | 0.34% | 29 |
|
|
2025
Q1 | $4.38M | Hold |
994,883
| – | – | 0.37% | 25 |
|
|
2024
Q4 | $6.72M | Buy |
994,883
+5,666
| +0.6% | +$38.2K | 0.4% | 22 |
|
|
2024
Q3 | $3.23M | Buy |
989,217
+14,549
| +1% | +$47.5K | 0.25% | 24 |
|
|
2024
Q2 | $6.28M | Buy |
974,668
+10,577
| +1% | +$68.2K | 0.48% | 18 |
|
|
2024
Q1 | $7.02M | Buy |
964,091
+94,648
| +11% | +$689K | 0.73% | 18 |
|
|
2023
Q4 | $8.09M | Buy |
869,443
+19,443
| +2% | +$181K | 0.9% | 20 |
|
|
2023
Q3 | $8.25M | Hold |
850,000
| – | – | 1.35% | 17 |
|
|
2023
Q2 | $18.3M | Buy |
850,000
+47,937
| +6% | +$1.03M | 2.52% | 11 |
|
|
2023
Q1 | $22.5M | Buy |
802,063
+62,905
| +9% | +$1.77M | 2.91% | 10 |
|
|
2022
Q4 | $16.6M | Buy |
739,158
+68,772
| +10% | +$1.55M | 2.55% | 11 |
|
|
2022
Q3 | $16M | Buy |
670,386
+240,386
| +56% | +$5.75M | 3.38% | 10 |
|
|
2022
Q2 | $12.5M | Buy |
430,000
+352,689
| +456% | +$10.3M | 3.2% | 10 |
|
|
2022
Q1 | $7.18M | Buy |
77,311
+39,065
| +102% | +$3.63M | 2.33% | 14 |
|
|
2021
Q4 | $3.65M | Buy |
+38,246
| New | +$3.65M | 1.95% | 17 |
|